Pharmalot Ed Silverman STAT Plus: Pharmalittle: Buttigieg wants pharma to ‘thrive’; U.S. patent panel boosts Biogen, disappoints Gilead
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Feds may soon charge generic drug makers for price fixing
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Alnylam stock plunges after key clinical trial is ended
